PBIO (Pressure BioSciences) Change In Receivables : $0.01 Mil (TTM As of Jun. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Pressure BioSciences Change In Receivables?

Pressure BioSciences's change in receivables for the quarter that ended in Jun. 2024 was $-0.04 Mil. It means Pressure BioSciences's Accounts Receivable increased by $0.04 Mil from Mar. 2024 to Jun. 2024 .

Pressure BioSciences's change in receivables for the fiscal year that ended in Dec. 2023 was $0.14 Mil. It means Pressure BioSciences's Accounts Receivable declined by $0.14 Mil from Dec. 2022 to Dec. 2023 .

Pressure BioSciences's Accounts Receivable for the quarter that ended in Jun. 2024 was $0.18 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Pressure BioSciences's Days Sales Outstanding for the three months ended in Jun. 2024 was 39.79.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Pressure BioSciences's liquidation value for the three months ended in Jun. 2024 was $-43.68 Mil.

Pressure BioSciences Change In Receivables Historical Data

The historical data trend for Pressure BioSciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pressure BioSciences Change In Receivables Chart

Pressure BioSciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

0.25

0.10

-0.02

-0.14

0.14

Pressure BioSciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Change In Receivables	Get a 7-Day Free Trial															0.20	-0.14	0.18	0.01	-0.04

Pressure BioSciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

Pressure BioSciences (OTCPK:PBIO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Pressure BioSciences's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.184	/	0.422	*	91
=	39.79

2. In Ben Graham's calculation of liquidation value, Pressure BioSciences's accounts receivable are only considered to be worth 75% of book value:

Pressure BioSciences's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.014	-	44.107	+	0.75 * 0.184	+	0.5 * 0.542
=	-43.68

Pressure BioSciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of Pressure BioSciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Pressure BioSciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pressure BioSciences Inc (OTCPK:PBIO) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

14 Norfolk Avenue, South Easton, MA, USA, 02375

Website

https://www.pressurebiosciences.com

Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.

Executives

Daniel Joseph Shea	officer: Senior Vice President & CFO	2 MINUTEMAN ROAD, MEDFIELD MA 02052
Bradford Addison Young	officer: Chief Commercial Officer	513 LITTLE JOHN HILL, ANNAPOLIS MD 21405
Richard T Schumacher	director, officer: Chief Executive Officer	375 WEST STREET, WEST BRIDGEWATER MA 02379
Nathan Lawrence	other: VP Sales and Marketing	321 MANLEY STREET, WEST BRIDGEWATER MA 02379
Richard Thomley	officer: Chief Financial Officer	C/O PRESSURE BIOSCIENCES, INC., 14 NORFOLK AVE., SOUTH EASTON MA 02375
Kevin Pollack	director	150 RAINVILLE ROAD, TARPON SPRINGS FL 34689
Michael S Urdea	director	100 BUNCE MEADOWS DRIVE, ALAMO CA 94507
Alexander V Lazarev	officer: VP of REsearch and Development	18 WINCHESTER DRIVE, LEXINGTON MA 02420
Edmund Y Ting	officer: Senior VP of Engineering	23642 123RD PLACE SOUTHEAST, KENT WA 48031
Vito J Mangiardi	director	12 POINT GALLINAS ROAD, SAN RAFAEL CA 94903
Jeffrey N Peterson	director	1031 SHORELINE DRIVE, SAN MATEO CA 94404
Mir Conrad F	officer: CFO	19 BRIER LANE, CLIFTON NJ 07012
Clayton A Struve	10 percent owner	175 W JACKSON BLVD, SUITE 440, CHICAGO IL 60604
Css Llc/il	other: (a)	175 WEST JACKSON BLVD, SUITE 440, CHICAGO IL 60604
R Wayne Fritzsche	director	835 GREENS PARKWAY, SUITE 150, HOUSTON TX 77067